Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Kane Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$0.1

2024-10-29

Market Capitalization

$16.6 M

2024-10-29

Revenue

$427 K

FY, 2025

CreditSafe Score

?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CADFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue506.0K1.7M1.3M1.6M2.7M2.8M3.2M427.0K
Cost of goods sold391.0K1.0M815.0K851.0K1.3M1.2M1.4M266.0K
Gross profit115.0K663.0K526.0K757.0K1.4M1.6M1.7M161.0K
Gross profit margin, %39.2%39.2%47.1%53.0%57.7%54.3%37.7%
Operating expense total3.2M4.2M4.8M5.5M4.8M5.5M5.2M2.7M
Depreciation and amortization71.0K54.0K188.0K238.0K219.0K162.0K
EBITDA(3.1M)(3.5M)(4.2M)(4.7M)(3.4M)(3.8M)5.6M(2.5M)
EBITDA margin, %-208.9%-315.1%-292.0%-126.1%-136.6%176.9%-583.6%
EBIT(3.2M)(813.0K)(3.8M)(4.6M)(3.1M)(4.1M)5.4M(2.6M)
EBIT margin, %-48.0%-280.8%-283.6%-116.5%-144.9%170.0%-611.2%
Interest income10.0K1.0K38.0K122.0K100.0K61.0K14.0K19.0K
Interest expense90.0K142.0K121.0K416.0K822.0K1.2M549.0K242.0K
Pre tax profit(3.3M)(960.0K)(3.8M)(4.8M)(3.8M)(5.3M)4.9M(2.8M)
Income tax expense(1.3M)(108.0K)
Net Income(3.3M)(960.0K)(3.8M)(4.8M)(3.8M)(5.3M)6.2M(2.7M)

Footer menu